Amarin | AMRN - Ebit

Cena Akcji
14.92
Dzienna Zmiana
0.08 0.51%
Miesięcznie
0.91%
Rocznie
43.28%
Q2 Prognozy TE
13.65




Ebit Zmiana Data
AbbVie USD 4.73B 1.08B 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
DBV Technologies USD -34.28M 6.83M 2025-09
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.18B 118M 2026-03